Edition:
United States

GW Pharmaceuticals PLC (GWPRF.PK)

GWPRF.PK on OTC Markets Group

8.40USD
18 Aug 2017
Change (% chg)

$-0.55 (-6.15%)
Prev Close
$8.95
Open
$8.45
Day's High
$9.00
Day's Low
$8.40
Volume
954
Avg. Vol
3,171
52-wk High
$11.53
52-wk Low
$6.69

GWPRF.PK

Chart for GWPRF.PK

About

GW Pharmaceuticals plc is a biopharmaceutical company focused on developing and commercializing therapeutics from its cannabinoid product platform in a range of disease areas. The Company's lead cannabinoid product candidate is Epidiolex, which is a liquid formulation of pure plant-derived cannabidiol (CBD). The Company offers... (more)
No analyst recommendations are available for GWPRF.PK.

Overall

Beta: 1.37
Market Cap(Mil.): £1,995.32
Shares Outstanding(Mil.): 25.33
Dividend: --
Yield (%): --

Financials

  GWPRF.PK Industry Sector
P/E (TTM): -- 79.67 32.70
EPS (TTM): -0.35 -- --
ROI: -38.35 2.87 14.88
ROE: -41.13 5.20 16.12

Earnings vs. Estimates